Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze PCG stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate PCG investment potential.

What is PCG stock price today?

Get real-time PCG stock price, historical data, and price charts on Financhill. Track PCG performance with our advanced analysis tools.

Is PCG a good investment?

Evaluate PCG investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy PCG stock?

To buy PCG stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of PCG?

View detailed market capitalization data and company valuation metrics for PCG on our comprehensive analysis page.

What is the P/E ratio of PCG?

Use our fundamental analysis tools to view PCG P/E ratio and compare valuation metrics with industry peers.

What are PCG earnings?

View PCG earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

PG&E Corp. 10K Form

Buy

PCG
PG&E Corp.

Last Price:

$19.00

Seasonality Move:

1.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-04-25	10Q	PCG/PG&E Corp. Quarterly
2024-02-22	10K	PCG/PG&E Corp. Annual
2023-10-26	10Q	PCG/PG&E Corp. Quarterly
2023-07-27	10Q	PCG/PG&E Corp. Quarterly
2023-05-04	10Q	PCG/PG&E Corp. Quarterly
2023-02-23	10K	PCG/PG&E Corp. Annual

Receive PCG News And Ratings

See the #1 stock for the next 7 days that we like better than PCG

PCG Financial Statistics

Sales & Book Value

Annual Sales:	$24.9B
Cash Flow:	$-1.2B
Price / Cash Flow:	0
Annual Sales:	$14.09
Price / Book:	1.34

Profitability

EPS (TTM):	1.16530
Net Income (TTM):	$2.7B
Gross Margin:	$4.9B
Return on Equity:	8.57%
Return on Assets:	1.91%

PG&E Corp. Earnings Forecast

Key PG&E Corp. Financial Ratios

The Gross Profit Margin over the past 46 years for PCG is 19.59%.
The Selling, General & Administrative Expenses for PCG have been equal to 0.00% of Gross Profit Margin.
The Research & Development expenses have been 0.00% of Revenue.
The Interest Expense is 112.02% of Operating Income.
The Net Earning history of PCG is 10.84% of Total Revenues.
Per Share Earnings over the last 46 years have been positive in 22 years.

PG&E Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	S&P500
Industry:	Electric Utilities
Sector:	Utilities
Current Symbol:	PCG
CUSIP:	69331C
Website:	pgecorp.com

Debt

Debt-to-Equity Ratio:	1.88
Current Ratio:	0.97
Quick Ratio:	0.7

Price-to-Earnings

Trailing P/E Ratio:	16.03
Forward P/E Ratio:	10.5

PCG Technical Analysis vs Fundamental Analysis

Buy

PG&E Corp. (PCG) is a Buy

Is PG&E Corp. a Buy or a Sell?

PG&E Corp. stock is rated a Buy

The current PG&E Corp. [PCG] share price is $18.88. The Score for PCG is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.